Pfizer to bid against Daiichi for Ranbaxy, sources say

06/12/2008 | Bloomberg · Business Standard (India)

Pfizer may make a hostile offer to acquire Ranbaxy Laboratories Ltd., competing against Daiichi Sankyo Co., which has agreed to pay as much as $4.6 billion for the Indian generic-drug maker, sources say. Pfizer's India unit refused to comment. A spokesman for Ranbaxy, however, said the Daiichi takeover "is binding and sealed."

View Full Article in:

Bloomberg · Business Standard (India)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Actuary
Meridian Health Plan
Detroit, MI
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC